Brief: Tivic Health Systems Q1 Net Income USD -1.481 Million
May 15 (Reuters) - Tivic Health Systems Q1 operating expenses USD 1.648 million. * Q1 operating income USD -1.481 million * Q1 basic EPS USD -1.01 * Q1 revenue USD 334 thousand * Q1 gross profit USD 167 thousand
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital